Infection Viral Clinical Trial
Official title:
A Prospective, Non-randomized, Non-controlled Trial: Initial Intravitreal Injection of High-dose Ganciclovir for Cytomegalovirus Retinitis in HIV-negative Patients
This prospective, non-randomized, non-controlled clinical trial was conducted to examine the clinical outcomes achieved by using initial high-dose intravitreal ganciclovir injections of ganciclovir in treating cytomegalovirus (CMV) retinitis in patients without human immunodeficiency virus (HIV) infection.
Cytomegalovirus retinitis (CMVR) is a serious vision-threatening disease. Intravitreal antiviral drug delivery was used as first-line treatment in several studies when systematic injection has been ruled out. The reported dose of intravitreal injections of ganciclovir (IVG) varied from 200 μg/0.1 ml to 5mg/0.1 ml in patients with AIDS. There was no consensus on the dose of ganciclovir in the treatment of CMVR in HIV-negative patients. Previous work showed the safety and the efficacy of 1mg IVG. The investigators proposed that a higher dose of ganciclovir (6mg/0.1ml) for the first injection followed by lower dose for maintenance may indicate a better result. Therefore, this study was performed to evaluate the therapeutic effect and safety of initial high-dose IVG for CMVR in HIV-negative patients. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06178822 -
Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room
|
||
Completed |
NCT05041764 -
RNA Sequencing of Individual Versus Wastewater - SARS-CoV2
|
||
Completed |
NCT04239521 -
The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
|
||
Recruiting |
NCT03818334 -
Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies
|
Phase 2/Phase 3 | |
Completed |
NCT04637867 -
COVID-19 - Multicentre Study on Nosocomial Transmission of SARS-CoV-2 Virus: an Ancillary Study (NOSO-COR IMMUNO)
|
N/A | |
Recruiting |
NCT06149494 -
RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
|
Phase 2 | |
Completed |
NCT05069623 -
A Phase 1/2 Study to Determine Safety and Immunogenicity of Two COVID 19 Vaccines VB10.2129 (RBD Candidate) and VB10.2210 (T Cell Candidate) Previously Vaccinated in Healthy Adult Volunteers
|
Phase 1/Phase 2 | |
Recruiting |
NCT04386460 -
Covid-19 and Prevention of Malnutrition After Confinement by Dentists
|
||
Completed |
NCT04290780 -
COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus
|
||
Completed |
NCT04327180 -
PREdiction of DIagnosed Covid-19 infecTion in IUC Patients
|
||
Recruiting |
NCT04438629 -
Evaluation of Immune Response in COVID-19 Patients
|
||
Active, not recruiting |
NCT05874713 -
Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in Adults
|
Phase 2 | |
Completed |
NCT03163628 -
biomArkers to differeNtiate bacTerial From vIral iNfEctions
|
N/A | |
Completed |
NCT04924842 -
COVID-19 - SARS-CoV-2 Community Contamination in Children and Adults - Impact of Variants (Dyn3CEA - Nosocor Phase 2)
|
||
Completed |
NCT04354155 -
COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial
|
Phase 2 | |
Recruiting |
NCT05875961 -
Study to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vaccines in Adults
|
Phase 1 | |
Recruiting |
NCT06379061 -
Access MeMed BV Assay Clinical Study Collection Protocol - Infectious Adult and Pediatric Cohorts
|
||
Active, not recruiting |
NCT04481529 -
COVID-19 Serological Status of Hospital Staff Working or Not in the COVID-19 Sector
|
||
Recruiting |
NCT05090319 -
Micro-hematology Analyzer for Viral/Bacterial Description
|
||
Not yet recruiting |
NCT04887233 -
Efficacy and Safety of Longan Extract Spray (P80 Spray) in Volunteers With Coronavirus Disease 2019 (COVID-19)
|
N/A |